Dalton Bioanalytics specializes in advanced analytical technologies aimed at enhancing the understanding of biological systems and improving drug development processes. The company focuses on mass spectrometry and other high-resolution analytical techniques to provide precise and reliable data for biomolecular analysis. Their innovative approaches enable researchers to gain insights into complex biological interactions, facilitating the identification and quantification of biomolecules in various samples.

In addition to mass spectrometry, Dalton Bioanalytics employs cutting-edge methodologies for data analysis and interpretation, which are crucial for translating raw data into actionable insights. Their technologies are designed to support a wide range of applications, including biomarker discovery, pharmacokinetics, and toxicology studies. By integrating these advanced analytical tools, Dalton Bioanalytics aims to streamline the research and development pipeline, ultimately contributing to more effective therapeutic solutions.

United States

Dalton Bioanalytics is developing new analytical technology to unlock access to the wealth of information available in blood in pursuit of greater human health.

Dalton has plans to resolve the inefficiency and expense that plagues traditional laboratory testing by digitizing the biochemical composition of blood and translating that digital signature into a comprehensive array of actionable health insights.

The company is named after John Dalton—the father of modern atomic theory and eponym of the atomic mass unit—in recognition of mass spectrometry, its core enabling technology.

Dalton Bioanalytics

Company Details